IRVINE, California and AMSTERDAM, December 15, 2010 /PRNewswire/ --- Second Independent Validation Study of ColoPrint Selected for Oral Presentation and Press Conference at ASCO GI in January 2011Agendia, a world leader in molecular cancer diagnostics, announced today that together with principal investigators from Spain, the UK, and the Netherlands, it has published the ... Continue Reading